.avia-section.av-jj6q5aec-609acd33511691f6550b6c559d25f43a .av-parallax .av-parallax-inner{
background-repeat:no-repeat;
background-image:url(https://medi-paper.com/wp-content/uploads/2019/04/Atezolizumab-with-or-without-cobimetinib-vs-regorafenib-for-previously-treated-metastatic-colorectal-cancer-IMblaze370.jpg);
background-position:50% 0%;
background-attachment:scroll;
}

.flex_column.av-ar50hsg-3cc348ea543e9639427066b5fbb41753{
border-radius:0px 0px 0px 0px;
padding:0px 0px 0px 0px;
}

#top .av-special-heading.av-x1tbcb-72f45b9938a3b9fe44c2ad49754144e8{
padding-bottom:10px;
}
body .av-special-heading.av-x1tbcb-72f45b9938a3b9fe44c2ad49754144e8 .av-special-heading-tag .heading-char{
font-size:25px;
}
.av-special-heading.av-x1tbcb-72f45b9938a3b9fe44c2ad49754144e8 .av-subheading{
font-size:15px;
}

.flex_column.av-9f3kjrk-47dcc1ce371c09fc62675e011cf87844{
border-radius:0px 0px 0px 0px;
padding:0px 0px 0px 0px;
}

#top .av-special-heading.av-jus6m8o7-02667d9504b0524d0bb902eed68626e1{
padding-bottom:10px;
}
body .av-special-heading.av-jus6m8o7-02667d9504b0524d0bb902eed68626e1 .av-special-heading-tag .heading-char{
font-size:25px;
}
.av-special-heading.av-jus6m8o7-02667d9504b0524d0bb902eed68626e1 .av-subheading{
font-size:15px;
}

.flex_column.av-8g1qg9c-6c3cd477385aff7cb30b7fb5df43cf99{
border-width:2px;
border-color:#999999;
border-style:solid;
border-radius:6px 6px 6px 6px;
padding:2% 2% 2% 2%;
background-color:#ffffff;
}

.flex_column.av-7lxqj5c-641a5887b684828e28acb6e8833ffdae{
border-radius:0px 0px 0px 0px;
padding:0px 0px 0px 0px;
}

#top .hr.hr-invisible.av-3qlcpni-6891b74538efe7dff0297f671cd06986{
height:30px;
}

#top .hr.hr-invisible.av-3qlcpni-6891b74538efe7dff0297f671cd06986{
height:30px;
}

#top .hr.hr-invisible.av-3qlcpni-6891b74538efe7dff0297f671cd06986{
height:30px;
}

#top .hr.hr-invisible.av-3qlcpni-6891b74538efe7dff0297f671cd06986{
height:30px;
}

#top .hr.hr-invisible.av-3qlcpni-6891b74538efe7dff0297f671cd06986{
height:30px;
}

.flex_column.av-3m46uwk-f889782a8d4cbc12ba7e3e34679ed599{
border-width:2px;
border-color:#cccccc;
border-style:solid;
border-radius:6px 6px 6px 6px;
padding:2% 2% 2% 2%;
}

#top .hr.hr-invisible.av-4m2oic-bcecdd3076a1c96d2ddd3e0975192e70{
height:30px;
}

.flex_column.av-caz79a-8cf9a2831c02ec2acf1d381c0d2ac56b{
border-radius:0px 0px 0px 0px;
padding:0px 0px 0px 0px;
}

#top .av_textblock_section.av-jkw44x4s-294185cf07c2b688026f5a91c33f80a4 .avia_textblock{
font-size:10px;
}

#top .hr.hr-invisible.av-36o83i6-9b5d8a263142f25512f0df5127a9e6e6{
height:30px;
}

#top .hr.hr-invisible.av-1yoncou-26cab26da9dc4b7bd16455d0518ecd1e{
height:30px;
}

#top .av_textblock_section.av-jkw4586a-e8ea51402051728c108f28bebf7f12bb .avia_textblock{
font-size:10px;
}